Cargando…

Author Correction: Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy

Detalles Bibliográficos
Autores principales:	Yoon, Jihyun, Yoon, Wontae, Na, Seung kwan, Lee, Jihyun, Kim, Chul Gu, Kim, Jong Woo, Cho, Han Joo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440530/ https://www.ncbi.nlm.nih.gov/pubmed/34521961 http://dx.doi.org/10.1038/s41598-021-98358-1

Ejemplares similares

Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy
por: Yoon, Jihyun, et al.
Publicado: (2021)

Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
por: Jung, Byung Ju, et al.
Publicado: (2019)

Characteristics of pachychoroid neovasculopathy
por: Tagawa, Miho, et al.
Publicado: (2020)

The implications of subretinal fluid in pachychoroid neovasculopathy
por: Lee, Geun Woo, et al.
Publicado: (2021)

Choroidal caverns in pachychoroid neovasculopathy
por: Ayachit, Apoorva, et al.
Publicado: (2020)

Impact of macular fluid features on outcomes of anti-vascular endothelial growth factor treatment for type 3 macular neovascularization
por: Yoon, Wontae, et al.
Publicado: (2021)

Pachychoroid neovasculopathy in extramacular choroidal neovascularization
por: Gupta, Mrinali Patel, et al.
Publicado: (2016)

Association of IL-4 with pachychoroid neovasculopathy
por: Baba, Takashi, et al.
Publicado: (2023)

Treatment outcomes of pachychoroid neovasculopathy with photodynamic therapy and anti-vascular endothelial growth factor
por: Roy, Rupak, et al.
Publicado: (2019)

Photodynamic therapy combined with anti-vascular endothelial growth factor therapy for pachychoroid neovasculopathy
por: Miki, Akiko, et al.
Publicado: (2021)

Pachychoroid neovasculopathy and age-related macular degeneration
por: Miyake, Masahiro, et al.
Publicado: (2015)

Remodeling of macular vortex veins in pachychoroid neovasculopathy
por: Matsumoto, Hidetaka, et al.
Publicado: (2019)

Neovascular age-related macular degeneration in which exudation predominantly occurs as a subretinal fluid during anti-vascular endothelial growth factor treatment
por: Cho, Han Joo, et al.
Publicado: (2022)

Multimodal Imaging in Pachychoroid Neovasculopathy: A Case Report
por: Biçer, Özlem, et al.
Publicado: (2018)

A Case of Best Disease Accompanied by Pachychoroid Neovasculopathy
por: Batıoğlu, Figen, et al.
Publicado: (2019)

Two-Thirds Dose Photodynamic Therapy for Pachychoroid Neovasculopathy
por: Tanaka, Koji, et al.
Publicado: (2021)

Effects of Intravitreous Aflibercept Injection in Pachychoroid Neovasculopathy: Comparison with Typical Neovascular Age-Related Macular Degeneration
por: Elfandi, Sufian, et al.
Publicado: (2021)

Vanishing pachy-choroid in pachychoroid neovasculopathy under long-term anti-vascular endothelial growth factor therapy
por: Schworm, Benedikt, et al.
Publicado: (2021)

Ranibizumab non-response in pachychoroid neovasculopathy: Effects of switching to aflibercept
por: Schworm, Benedikt, et al.
Publicado: (2020)

Chronic choriocapillaris ischemia in dilated vortex vein region in pachychoroid neovasculopathy
por: Matsumoto, Hidetaka, et al.
Publicado: (2021)

Choroidal Morphology on Ultra-Widefield Indocyanine Green Angiography and Response to Aflibercept in Pachychoroid Neovasculopathy
por: Han, Su Yeon, et al.
Publicado: (2023)

Occlusion of a Vortex Vein After Treatment With Half-Fluence Photodynamic Therapy Combined With Intravitreal Aflibercept Injection for Pachychoroid Neovasculopathy
por: Yamada, Chizu, et al.
Publicado: (2022)

Progression of Subclinical Pachychoroid Neovasculopathy to an Active Neovascularization in the Presence of Acquired Vitelliform Lesions
por: Soman, Manoj, et al.
Publicado: (2021)

Pachychoroid neovasculopathy can mimic wet type age-related macular degeneration
por: Farvardin, Mohsen, et al.
Publicado: (2022)

Scleral Thickness as a Risk Factor for Central Serous Chorioretinopathy and Pachychoroid Neovasculopathy
por: Keidel, Leonie F., et al.
Publicado: (2023)

One-Year Outcome of Combination Therapy with Full or Reduced Photodynamic Therapy and One Anti-Vascular Endothelial Growth Factor in Pachychoroid Neovasculopathy
por: Sato-Akushichi, Miki, et al.
Publicado: (2022)

Complement Activation Products and Cytokines in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration
por: Kato, Yutaka, et al.
Publicado: (2020)

Analysis focusing on plasma von Willebrand factor in pachychoroid neovasculopathy and age-related macular degeneration
por: Hirai, Hiromasa, et al.
Publicado: (2021)

Distinct Aqueous Humour Cytokine Profiles of Patients with Pachychoroid Neovasculopathy and Neovascular Age-related Macular Degeneration
por: Terao, Nobuhiro, et al.
Publicado: (2018)

The association of choroidal structure and its response to anti-VEGF treatment with the short-time outcome in pachychoroid neovasculopathy
por: Azuma, Keiko, et al.
Publicado: (2019)

Pachychoroid Neovasculopathy Disguising as Age-Related Macular Degeneration Treated by Spironolactone and Anti-VEGF Combination Therapy
por: Keidel, Leonie F., et al.
Publicado: (2021)

Pachychoroid neovasculopathy has clinical properties that differ from conventional neovascular age-related macular degeneration
por: Kuranami, Ai, et al.
Publicado: (2023)

Optical coherence tomography-based misdiagnosis and morphological distinction in pachychoroid neovasculopathy vs. polypoidal choroidal vasculopathy
por: Siedlecki, Jakob, et al.
Publicado: (2023)

Pachychoroid neovasculopathy versus macular neovascularization in age-related macular degeneration with and without shallow irregular pigment epithelial detachment
por: Riazi-Esfahani, Hamid, et al.
Publicado: (2023)

A Comparative Study of Short-Term Vascular and Stromal Alterations of the Choroid Following Half-Fluence Photodynamic Therapy in Pachychoroid Neovasculopathy and Chronic Central Serous Chorioretinopathy
por: Yanık, Özge, et al.
Publicado: (2022)

Neovascular age-related macular degeneration without exudative recurrence over 24 months after initial remission
por: Cho, Han Joo, et al.
Publicado: (2022)

Author Correction: Increase in the Population of Patients with Neovascular Age-Related Macular Degeneration Who Underwent Long-Term Active Treatment
por: Baek, Seung Kook, et al.
Publicado: (2020)

Intravitreal Anti-vascular Endothelial Growth Factor for Newly Diagnosed Symptomatic Polypoidal Choroidal Vasculopathy with Extrafoveal Polyps
por: Kim, Jae Hui, et al.
Publicado: (2015)

Intravitreal Anti-vascular Endothelial Growth Factor for Treating Polypoidal Choroidal Vasculopathy with Grape-like Polyp Clusters
por: Chang, Young Suk, et al.
Publicado: (2016)

Visual Outcome and Treatment Frequency of Anti-VEGF Therapy Using the Treat-and-Extend and Treatment Cessation Regimen for Exudative Age-Related Macular Degeneration and Pachychoroid Neovasculopathy
por: Kinoshita, Takamasa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9b2c6um4qpe7dlj1e4ov4h1elo